Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa
24 juin 2024 03h00 HE
|
Acino International AG
Saint-Louis, France and Weil am Rhein, Germany and Zurich, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- Allecra Therapeutics (“Allecra”) and Acino today announced the signing of an exclusive...
Acino significantly expands presence and capabilities in Latin America through acquisition of M8 Pharmaceuticals
20 sept. 2023 07h59 HE
|
Acino International AG
Zurich, Switzerland, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Acino, a Swiss pharmaceutical company headquartered in Zurich, today announced that it has entered into an agreement to acquire M8...
Acino acquires selected Aspen brands in South Africa
22 oct. 2021 02h17 HE
|
Acino International AG
Zurich, Oct. 22, 2021 (GLOBE NEWSWIRE) -- ZURICH, Switzerland, 22 October 2021 - Acino and Aspen Pharmacare Holdings Limited and its subsidiaries (collectively, “Aspen”) have signed an agreement for...